Louisiana's 'Netflix' deal for hepatitis C drugs wins bids from AbbVie, Gilead and Merck

Louisiana is moving forward with a flat-rate payment system for purchasing hepatitis C drugs, and so far, the field's top players are on board. Washington state has its own, similar plans—and if the "Netflix" model works, others may well follow.